$1.050
+0.102 (+9.69%)At close
STXS Profitability and Margins
Evaluating the bottom line, Stereotaxis Inc maintains a gross margin of 58.49%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -51.19%, while the net margin is -58.25%. These profitability ratios, combined with a Return on Equity (ROE) of -344.36%, provide a clear picture of how effectively STXS converts its operational activities into shareholder value.
STXS Comparative Benchmarking
In the context of the broader market, STXS competes directly with industry leaders such as NRXS and LUCD. With a market capitalization of $105.21M, it holds a leading position in the sector. When comparing efficiency, STXS's gross margin of 58.49% stands against NRXS's 85.87% and LUCD's -5.16%. Such benchmarking helps identify whether Stereotaxis Inc is trading at a premium or discount relative to its financial performance.
Stereotaxis Inc Financial Performance
Stereotaxis reported a total revenue of $7.67 million for Q2 2026, down 12% year-over-year, with a net loss of $4.78 million, which is wider than the previous year's loss. The gross margin has been improving, reaching 58.49% in Q2 2026, indicating some operational efficiency.
Financials
Related articles
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.